Chiesi Farmaceutici

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.

By changing its legal status to a Benefit Corporation in Italy, the US, France and Colombia, Chiesi has made its commitment to creating shared value for society legally binding and central to company-wide decision-making. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. The company also aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.

One of Chiesi’s main drivers of growth is our people. Putting people first means fostering their professional and personal development, ensuring their wellbeing, and creating an environment where everyone can thrive. This commitment has led Chiesi to be recognized as a Great Place To Work and to earn the Top Employers Certification, which awards organizations that reach the highest standards of excellence in employee conditions, culture, training, development, and career opportunities.